1308 related articles for article (PubMed ID: 16863503)
1. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
2. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
Singh SK; Hajeri PB
Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li SD; Huang L
Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
[TBL] [Abstract][Full Text] [Related]
4. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
5. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
6. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery.
Gary DJ; Puri N; Won YY
J Control Release; 2007 Aug; 121(1-2):64-73. PubMed ID: 17588702
[TBL] [Abstract][Full Text] [Related]
7. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
8. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
Aigner A
Expert Opin Biol Ther; 2009 Dec; 9(12):1533-42. PubMed ID: 19769540
[TBL] [Abstract][Full Text] [Related]
9. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
10. Strategies for short hairpin RNA delivery in cancer gene therapy.
Wang SL; Yao HH; Qin ZH
Expert Opin Biol Ther; 2009 Nov; 9(11):1357-68. PubMed ID: 19761417
[TBL] [Abstract][Full Text] [Related]
11. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
Vorhies JS; Nemunaitis J
Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
[TBL] [Abstract][Full Text] [Related]
12. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
13. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
Wang SL; Yao HH; Guo LL; Dong L; Li SG; Gu YP; Qin ZH
Cancer Genet Cytogenet; 2009 Apr; 190(1):8-14. PubMed ID: 19264227
[TBL] [Abstract][Full Text] [Related]
14. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
15. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242
[TBL] [Abstract][Full Text] [Related]
16. siRNA therapeutics: big potential from small RNAs.
Ryther RC; Flynt AS; Phillips JA; Patton JG
Gene Ther; 2005 Jan; 12(1):5-11. PubMed ID: 15496962
[TBL] [Abstract][Full Text] [Related]
17. RNA interference (RNAi) in hematology.
Scherr M; Steinmann D; Eder M
Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
[TBL] [Abstract][Full Text] [Related]
18. Short interfering RNA (siRNA): tool or therapeutic?
Cejka D; Losert D; Wacheck V
Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide application of RNAi to the discovery of potential drug targets.
Ito M; Kawano K; Miyagishi M; Taira K
FEBS Lett; 2005 Oct; 579(26):5988-95. PubMed ID: 16153642
[TBL] [Abstract][Full Text] [Related]
20. RNAi in functional genomics.
Scherr M; Eder M
Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
